{"name":"Draig Therapeutics Ltd","slug":"draig-therapeutics-ltd","ticker":"","exchange":"","domain":"draig.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DT-101","genericName":"DT-101","slug":"dt-101","indication":"Breast cancer, estrogen receptor-positive, HER2-negative","status":"phase_2"}]}],"pipeline":[{"name":"DT-101","genericName":"DT-101","slug":"dt-101","phase":"phase_2","mechanism":"DT-101 is a small molecule that targets the CDK4/6 pathway.","indications":["Breast cancer, estrogen receptor-positive, HER2-negative","Breast cancer, estrogen receptor-positive, HER2-positive"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOTDNTSWFiZ0RtbWpybHk3dUctNklnTXg1MVRnVVdiR1hXLUh2WTJFakN4RGJiNEtPU001M1Rwb0YwYmZycDc2WEswV2t5UlVwQnpfa1EtODNRZ3U1b3NVdzZ3UU9TeWdaZ3Q0S3lOU1lqQjFFaENlSHN2YzFZWVdDbjFBbFo0bXVkazlHQmljczh0MHh5YmlObm4yTXNibHYtZm9tRGpXZlFrUkp6bjQwdA?oc=5","date":"2025-11-05","type":"pipeline","source":"Pharmafile","summary":"Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO - Pharmafile","headline":"Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPRVktd1hLd0pkOGdndGJPNXpndm1XTk5Vb3dxT1ZvZDlhU1h4NDJrNHNsaHNIRUhSbU9oNEVwM2NRRWhBbUVORXg2WGthSkVjV3EzMzR6VEVUSzQ4OTJqTllaV3JSeWNRQU1NM1ZqMFZvcW5NRmFIRzg2S0ZSdGlGZmVhYmhqalZaSm5QT3FybU9JbUx0WmlTVjJYMWpYd1ltNXVncDBoRkdiQzhiVVh4ZEtmVXNjODJHYjQxd0VZdw?oc=5","date":"2025-06-20","type":"pipeline","source":"MedCity News","summary":"Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs - MedCity News","headline":"Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQNFZqVGpZTmRpOWlzLVhud3p2SUhZVjVOV0EwSGw2bGNJTHBhcHJpVUVsdXJETWltQ0IzVy1oakNwZkZLb1RmektKbU95aWR1R1kyU19WNXpwaGdiYlRxb2gxcklCX29INlJxOXRqNm9KelZtd0pwLXZZTl9UMXpVcnl6b0ZPMHlmQnhyQzhZcGxrNVVvQjhMcVZHZ1pBdw?oc=5","date":"2025-06-19","type":"pipeline","source":"Pharmaceutical Technology","summary":"Draig Therapeutics funding for neuropsychiatric disorder therapies - Pharmaceutical Technology","headline":"Draig Therapeutics funding for neuropsychiatric disorder therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxNQW12SnBuZmlHdGlKa0lDLUx5UmFPRWpTSk9hRkI5aHJPTndFNDQtSTJ1VjROOTZlUVRpZEx1akpXS0FKSkNCY25rRHFtX1NuOUhiVzBLVTdtMGNUZE9PUEpqZjVUX3pDN0VJZWZoS3gxTmJ4YTRBWmdDNEpFcTdNTzZmbjk4OTFWTENIcUxmb3UwRUgyeGlQS04wU3hjS0hrVlc3OFZYR2dHSGFPaGJOWHZhV0FRMTg2QjVJRU4zMGFGSHpaMWlVODRPMGdZSmtTblBNVWFmbXpaXzZyTkRxaThkTlFObTRNSkFEZ0ZRN0d2d0dobHpScVYxSGIxQkVoNnNQTWJsTzVjeDhEbUNyTUg2SlpfcVZ2aUJQd1U1ejNaRE1MQnRuUjVnSmowdkZiVnhRcm00cmVhcmJlV2FxTzR0R3otdGZXQ2t4TG1vcEVfQVhybUVr?oc=5","date":"2025-06-18","type":"pipeline","source":"GlobeNewswire","summary":"Draig Therapeutics Launches with $140 Million (£107 - GlobeNewswire","headline":"Draig Therapeutics Launches with $140 Million (£107","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9yamhSR3AxeXpfNlFXZk9SMFJ4dnczT0JxREpiQ0lLODhoSmhJYkFSang4ZGJuS0pFR09reDVwX1M3UElFWHA2SGRlaUgxM0pjdlhMWi1nNnZWT3BOZVN3ckFxUlp5WGQ5YkJ1ZmFaWTREQUluOEJkRUh3VGE?oc=5","date":"2025-06-18","type":"pipeline","source":"pharmaphorum","summary":"Welsh biotech Draig emerges with $140m in financing - pharmaphorum","headline":"Welsh biotech Draig emerges with $140m in financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQS2R2aVhWLW9SVDgwSWgwS0xMb18zMkJKN3NjMXRfOE1XeXptYzZYaEcxTVBON1dUcmk3TW1iWHdYTjdXQUt6RDVEVlMzVmZ5U0JMYm14Z0F2c3FYOXVSOFVVME05a3pHMkRjRDdpbjJWQWYyeC1Pal80RFdEUU5yNzRLNXBMU1FQSmJqVnh3U3drV0kxUFVoY1FSYXVaWGFyVUVJ?oc=5","date":"2025-06-18","type":"pipeline","source":"BioWorld News","summary":"Newly launched Draig targeting depression with $140M series A - BioWorld News","headline":"Newly launched Draig targeting depression with $140M series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNUVZMY0N2OHRFRnh1NWpRUG9VcWVFelQweW9DUnlTQnRUWU4zX2xsSDRiS2R4SjAtWWd3dWNvWlZ1czZxWTBTWnBuamRHcTJCV1JmQ1ZaY2hEVVQyRS1jZ0V1LXhKSk1KeWJaRG1jUS1SMEZoS2FaWktlek83ck5HbkprWDZDZU1veUhqVlFHTzVLUkFfZUZUcS1tN0VRSkV2cUlpZTBLYTd1S2ta?oc=5","date":"2025-06-18","type":"pipeline","source":"Fierce Biotech","summary":"Neuropsychiatry biotech Draig Therapeutics hatches with red-hot $140M series A - Fierce Biotech","headline":"Neuropsychiatry biotech Draig Therapeutics hatches with red-hot $140M series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNN0JaSUNTZVhpMTNwUXh1QklucjhJRURaamVBWjRuLXVJMk5HM1dwOXdvZ2VPRU5tX0VLZGQ2ZGZQQm81Q18xQW5sTG9iTHh0X24yQXcxNXhTTTZ2NEZIOXRHTUtBcHFNY29ibkRKS2dfeU16MWN3eDFwWjdFSVZNNUpOUzFpcERObThEZ0RuNVRLZmV1Y3Z2RQ?oc=5","date":"2025-06-18","type":"pipeline","source":"BioPharma Dive","summary":"Draig, a brain drug startup, debuts with $140M to treat depression - BioPharma Dive","headline":"Draig, a brain drug startup, debuts with $140M to treat depression","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}